CCA
ABBV icon

Childress Capital Advisors’s AbbVie ABBV Stock Holding History

Childress Capital Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.34M Sell
9,282
-969
-9% -$208K 0.38% 52
2026
Q1 		$2.23M Sell
10,251
-477
-4% -$106K 0.4% 41
2025
Q4 		$2.45M Buy
10,728
+1,040
+11% +$237K 0.39% 45
2025
Q3 		$2.24M Buy
9,688
+1,378
+17% +$281K 0.41% 44
2025
Q2 		$1.54M Buy
8,310
+1,667
+25% +$310K 0.39% 43
2025
Q1 		$1.39M Buy
6,643
+89
+1% +$17.3K 0.4% 46
2024
Q4 		$1.16M Sell
6,554
-69
-1% -$12.7K 0.32% 52
2024
Q3 		$1.31M Buy
6,623
+121
+2% +$22.6K 0.35% 49
2024
Q2 		$1.12M Buy
6,502
+138
+2% +$22.9K 0.31% 54
2024
Q1 		$1.16M Sell
6,364
-466
-7% -$80.3K 0.34% 52
2023
Q4 		$1.06M Buy
6,830
+251
+4% +$36.6K 0.32% 52
2023
Q3 		$983K Buy
+6,579
New +$966K 0.32% 55
2023
Q2 		– Sell
-2,123
Closed -$338K – 75
2023
Q1 		$338K Sell
2,123
-5,024
-70% -$768K 0.15% 61
2022
Q4 		$1.16M Buy
7,147
+531
+8% +$81.4K 0.38% 48
2022
Q3 		$899K Sell
6,616
-210
-3% -$30.1K 0.35% 53
2022
Q2 		$1.04M Buy
6,826
+293
+4% +$44.8K 0.41% 49
2022
Q1 		$1.06M Buy
6,533
+125
+2% +$18.2K 0.37% 50
2021
Q4 		$868K Sell
6,408
-1,655
-21% -$195K 0.36% 54
2021
Q3 		$869K Buy
8,063
+3,913
+94% +$447K 0.35% 58
2021
Q2 		$467K Sell
4,150
-3,711
-47% -$418K 0.21% 82
2021
Q1 		$850K Buy
7,861
+2,525
+47% +$270K 0.39% 49
2020
Q4 		$574K Buy
+5,336
New +$513K 0.34% 37

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Childress Capital Advisors's ABBV Position: Q2 2026 in Review

Childress Capital Advisors reduced its AbbVie (ABBV) stake by 9.5% in Q2 2026, selling an estimated $208K and leaving 9,282 shares worth $2.34M. The position accounts for 0.38% of the portfolio, ranked #52.

Childress Capital Advisors first reported a position in ABBV in Q4 2020 and has held it in 22 quarters since. The position peaked at $2.45M in Q4 2025. 4,220 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Childress Capital Advisors held 9,282 shares of AbbVie worth $2.34M as of Q2 2026.
  • Childress Capital Advisors sold 969 AbbVie shares in Q2 2026, an estimated $208K.
  • AbbVie made up 0.38% of Childress Capital Advisors's portfolio in Q2 2026, its #52 holding.
  • Childress Capital Advisors first reported a position in AbbVie in Q4 2020 and has held it in 22 quarters since.
  • Childress Capital Advisors's AbbVie position peaked at $2.45M in Q4 2025.
  • 4,220 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Childress Capital Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.